Plasminogen activator inhibitor-1

被引:61
|
作者
Gils, A [1 ]
Declerck, PJ [1 ]
机构
[1] Catholic Univ Louvain, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium
关键词
PAI-1; serpin; fibrinolysis; thrombosis;
D O I
10.2174/0929867043364595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is an important component of the plasminogen/plasmin system as it is the main inhibitor of tissue-type and urokinase-type plasminogen activator. Consequently, PAI-1 plays an important role in cardiovascular diseases (mainly through inhibition of t-PA) and in cell migration and tumor development (mainly through inhibition of u-PA). As a member of the serpin superfamily, PAI-1 shares important structural properties with other serpins. However, PAI-1 also exhibits unique conformational and functional properties. The current paper provides an overview of the knowledge on PAI-1 gathered since its discovery two decades ago. We are discussing (a) its structural properties and their subsequent association with the functional properties, (b) its role in a wide variety of (patho)physiological processes and (c) a number of strategies to interfere with its functional properties eventually aiming at pharmacological modulation of this risk factor.
引用
收藏
页码:2323 / 2334
页数:12
相关论文
共 50 条
  • [1] Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
    Johansson, L
    Jansson, JH
    Boman, K
    Nilsson, TK
    Stegmayr, B
    Hallmans, G
    [J]. STROKE, 2000, 31 (01) : 26 - 32
  • [2] Polymerization of plasminogen activator inhibitor-1
    Zhou, A
    Faint, R
    Charlton, P
    Dafforn, TR
    Carrell, RW
    Lomas, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9115 - 9122
  • [3] Plasminogen Activator Inhibitor-1 in Aging
    Yamamoto, Koji
    Takeshita, Kyosuke
    Saito, Hidehiko
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (06): : 652 - 659
  • [4] Plasminogen activator inhibitor-1 and the kidney
    Eddy, AA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (02) : F209 - F220
  • [5] PLASMINOGEN-ACTIVATOR INHIBITOR-1
    LOSKUTOFF, DJ
    MIMURO, J
    HEKMAN, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 534 - 534
  • [6] Plasminogen activator inhibitor-1 and Restenosis
    Garg, Nadish
    Fay, William P.
    [J]. CURRENT DRUG TARGETS, 2007, 8 (09) : 1003 - 1006
  • [7] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    [J]. STROKE, 1996, 27 (06) : 1066 - 1071
  • [8] Plasminogen activator inhibitor-1 and diabetic nephropathy
    Lee, HB
    Ha, H
    [J]. NEPHROLOGY, 2005, 10 : S11 - S13
  • [9] Biochemical properties of plasminogen activator inhibitor-1
    Dupont, Daniel Miotto
    Madsen, Jeppe Buur
    Kristensen, Thomas
    Bodker, Julie Stove
    Blouse, Grant Ellsworth
    Wind, Troels
    Andreasen, Peter Andre
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 1337 - 1361
  • [10] Plasminogen activator inhibitor-1 in vascular thrombosis
    Westrick, Randal J.
    Eitzman, Daniel T.
    [J]. CURRENT DRUG TARGETS, 2007, 8 (09) : 996 - 1002